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ABSTRACT Kv2.1 is a voltage-gated potassium (Kv) channel that generates delayed rectiﬁer currents in mammalian heart
and brain. The biophysical properties of Kv2.1 and other ion channels have been characterized by functional expression in
heterologous systems, and most commonly in Xenopus laevis oocytes. A number of previous oocyte-based studies of
mammalian potassium channels have revealed expression-level-dependent changes in channel properties, leading to the
suggestion that endogenous oocyte factors regulate channel gating. Here, we show that endogenous oocyte potassium
channel KCNE ancillary subunits xMinK and xMiRP2 slow the activation of oocyte-expressed mammalian Kv2.1 channels two-
to-fourfold. This produces a sigmoidal relationship between Kv2.1 current density and activation rate in oocyte-based two-
electrode voltage clamp studies. The effect of endogenous xMiRP2 and xMinK on Kv2.1 activation is diluted at high Kv2.1
expression levels, or by RNAi knockdown of either endogenous subunit. RNAi knockdown of both xMiRP2 and xMinK
eliminates the correlation between Kv2.1 expression level and activation kinetics. The data demonstrate a molecular basis for
expression-level-dependent changes in Kv channel gating observed in heterologous expression studies.
INTRODUCTION
Kv-channels are widely distributed in all excitable cells,
where they mediate cellular repolarization (1). Upon mem-
brane depolarization, Kv-channels open to facilitate rapid
efﬂux of K1 ions through a highly-selective pore (2,3). Kv-
channel a-subunits each possess six transmembrane domains
(Fig. 1 A), and can form functional channels as homote-
tramers (4) or subfamily-speciﬁc heterotetramers (5,6).
Kv-current diversity in vivo is generated by a variety of
mechanisms, one of which is coassembly of a-subunits with
a variety of different ancillary subunits, formingmixed channel
complexes with unique function, regulation, and pharma-
cology (7). One family of ancillary subunits, the MinK-
Related Peptides (MiRPs), comprises single transmembrane
domain proteins encoded by KCNE genes (8,9) (Fig. 1 A).
MinK and MiRPs coassemble somewhat promiscuously
with a range of Kv a-subunits with a variety of functional
effects (7). Mutations in KCNE1 (which encodes MinK) and
KCNE2 (which encodes MiRP1) are associated with inher-
ited and drug-induced cardiac arrhythmia in man (9–13); a
KCNE3 (encoding MiRP2) mutation is associated with
familial periodic paralysis (14). Thus, MinK and MiRPs are
considered obligate partners in some native channel com-
plexes.
MinK subunits coassemble with KCNQ1 Kv-channel
a-subunits to generate the IKs current in human ventricular
myocardium (15,16); MiRP1 coassembles with hERG to
form the cardiac IKr current (9). MiRP2 modulates Kv3.4
a-subunits in skeletal muscle (14), KCNQ1 in the colon (17),
and forms complexes with Kv2.1 and with Kv3.1 a-subunits
in rat brain (18). Heterologous coexpression studies have
shown that MiRP2 is particularly promiscuous, also sup-
pressing hERG currents (17) and slowing the gating of Kv3.2
and Kv3.1-Kv3.2 heteromers (19).
Kv2.1, a mammalian delayed rectiﬁer Kv-channel related
to the Shab family of Drosophila melanogaster, exhibits
moderately fast activation and deactivation and slow inac-
tivation (20,21). Kv2.1 channels mediate repolarization of
skeletal and cardiac muscles and central and peripheral
neurons, regulate tonic ﬁring in sympathetic neurons, and
generate the apoptotic response in cortical neurons (22–24).
The Xenopus laevis oocyte expression system, coupled
with two-electrode voltage-clamp electrophysiology, pro-
vides a robust, widely used system for studies of ion channel
function, particularly in medium-throughput analyses of ion
channel mutations and pharmacology (25). A number of
previous studies have shown that heterologously expressed
potassium channels inXenopus oocytes exhibit variable func-
tional properties depending upon the amount of a-subunit
cRNA injected (26–30). These ﬁndings contradict the dogma
that ion channels function independently of one another, and
prompted speculation that endogenous oocyte factors regu-
late heterologously-expressed channel function; effects of
the endogenous factors are proposed to be diluted at higher
a-subunit expression levels. Previously, we identiﬁed the
Xenopus MiRP gene family and showed that endogenous
oocyte xMiRP2 suppresses hERG currents heterologously
expressed in this system (31). Here, we show using RNA
interference (RNAi) that endogenously expressed oocyte
xMiRP2 and related protein xMinK dictate Kv2.1 activation
kinetics in Xenopus oocyte expression studies. The data
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demonstrate for the ﬁrst time that endogenous potassium
channel ancillary subunits in heterologous expression sys-
tems can account for expression-level-dependent changes in
channel gating, and suggest that previous studies of Kv2.1
function in Xenopus oocytes are of mixed Kv2.1-MiRP
channel complexes.
MATERIALS AND METHODS
Molecular biology
xMinK and xMiRP2 were cloned from cDNA isolated from RT-PCR from
stage V and stage VI Xenopus laevis oocytes mRNA as previously described
(31). For functional expression in oocytes, cRNA transcripts for xMinK,
xMiRP2, hMinK, hMiRP2, and rat Kv2.1 were produced in vitro using the
mMessage mMachine transcription kit (Ambion, Austin, TX) as before (31).
To avoid dilution errors, all oocytes were ﬁrst injected with the appropriate
a-subunit cRNA, then immediately afterwards injected with modifying
b-subunit cRNA transcripts or siRNA oligos.
For RNAi, 500 pg of double-stranded siRNA 21-mer oligos (Dharmacon,
Lafayette, CO) corresponding to bases 104–124 of xMiRP2 (top strand 59-
AAGGGAACCACACGGACGCCA-39) or bases 76–96 of xMinK (top
strand 59-AACUCCACGGCAAUAAAGUCU-39) were injected into oo-
cytes immediately after injection of a-subunit cRNA as previously described
(31,32). For assessment of RNAi gene silencing at the mRNA level, equal
amounts of oocytes were injected either with xMiRP2 cRNA, xMiRP2,
xMinK, or scrambled control siRNA; and RNA extracted using Trizol
(Invitrogen, Carlsbad, CA) the same day as functional experiments were
carried out, and on the same batch of oocytes. RNA concentration was
measured by spectrophotometry (SmartSpec3000; BioRad, Hercules, CA),
and RT-PCR was performed with Xenopus b-actin primers (forward, 59-
AAGGAGACAGTCTGTGTGCGTCCA-39; reverse, 59-CAACATGATT-
TCTGCAAGAGCTCC-39) to normalize mRNA concentration. Optical
density of cDNA samples size-fractionated on a 1% agarose gel and stained
with ethidium bromide was measured using a BioRad Fluor-S MultiImager
(BioRad). cDNA samples normalized to b-actin cDNA concentration were
subsequently ampliﬁed using xMinK- or xMiRP2-speciﬁc primers and
presence of speciﬁc cDNAs assessed after size fractionation and ethidium
bromide staining on a 1% agarose gel.
Biochemistry
Oocytes were lysed with 150 mM NaCl, 0.2 mM PMSF, 20 mM NaF, 10
mM Na3VO4, and 50 mM Tris (pH 7.4), and detergents, 1% NP-40, 1%
CHAPS, 1% Triton X-100, and 0.5% SDS. Samples were clariﬁed by two
separate centrifugations at 10,000 g for 20 min before addition of standard
SDS-PAGE loading buffer, and separation by SDS-PAGE on 15% gels.
After transfer to PVDFmembrane, Western blots were performed with an in-
house primary antibody raised by injection into rabbits of a mammalian
expression vector expressing full-length hMiRP2; detection was via goat
anti-rabbit horseradish peroxidase-coupled secondary antibodies (BioRad)
for ﬂuorography. Band intensities for assessment of RNAi efﬁciency at the
protein level were quantiﬁed using a BioRad Fluor-S MultiImager (BioRad).
Normalization to total protein concentration was not performed, because our
previous studies using the Bradford assay showed that normalization to
number of oocytes is sufﬁcient to achieve standardized total protein con-
centration (31).
Electrophysiology
Whole-cell currents in oocytes were recorded 1–2 days post-injection
at room temperature by TEVC using an OC-725C Ampliﬁer (Warner
Instruments, Hamden, CT), an IBM computer, and pCLAMP8 software
(Axon Instruments, Foster City, CA). Bath solution was 4 mM KCl, 96 mM
NaCl, 0.7 mM MgCl2, 1 mM CaCl2, and 10 mM HEPES (pH 7.4). In all
cases, recordings with a current density below 0.1 mA at 0 mV were
discarded to minimize the contribution of endogenous, non-Kv2.1 generated
oocyte currents in analyzed data. To eliminate IKs-like currents generated
from interaction of injected xMinK with endogenous xKCNQ1, the IKs-
speciﬁc blocker HMR1556 (33–35), generously provided by Aventis
Pharmaceuticals (Bridgewater, NJ), was included in the bath medium where
appropriate at a concentration of 5 mM. Kv2.1 activation traces were ﬁtted
with a double-exponential function. Changes in Kv2.1 activation rate were
associated with changes in both the fast and slow components of activation,
with no mean signiﬁcant changes in the relative amplitudes of the two
components (not shown). Therefore, for simplicity, scatter plots are of
current density versus tslow; similar effects were observed with equivalent
plots using tfast (not shown). Scatter plots were, where possible, ﬁtted with a
logistic dose response function, y ¼ [A1–A2/1 1 (x0/x)p] 1 A2, where x0 is
the half-maximal effect, and p is the slope factor; coefﬁcient of determi-
nation (R2) was noted to indicate wellness of ﬁt. Scatter plots that did not ﬁt
with a logistic dose response function were assumed to show no sigmoidal
relationship between current density and activation kinetics, and were
instead ﬁt with a straight line, y ¼ Bx 1 A; and values for y intercept (A),
slope (B), correlation coefﬁcient (R), standard deviation (SD), and signif-
icance level (p) reported (Table 1). Raw data were analyzed using pClamp9
software (Axon Instruments); ﬁtting of plots and statistical analyses
(ANOVA) were performed using Excel (MicroSoft, Redmond, WA) and
FIGURE 1 Kv2.1 activation kinetics vary with expression level. (A) Car-
toons showing predicted topologies of Kv2.1 andMinK (or related peptides).
(B) Exemplar current trace generated from TEVC of oocytes injected with
30 ng Kv2.1 cRNA. Oocytes were held at 80 mV and stepped to voltages
between80 and160 mV, with a40 mV tail pulse (protocol, upper inset;
scale bars, lower inset; zero current level, dashed line). (C) Scaled current at
0 mV for oocytes injected with 1, 18, or 30 ng of Kv2.1 cRNA (as indicated)
illustrating current density dependence of activation kinetics (zero current
level, dashed line). (D) Scatter plot of the relationship between the slow
component of activation (tslow) and current density of Kv2.1; oocytes were
injected with 1–30 ng Kv2.1 cRNA (n ¼ 223 oocytes). Data were ﬁt with a
sigmoidal relationship (solid line). (Inset) Slow component of Kv2.1
activation kinetics versus binned current density for oocytes as in scatter
plot. Asterisks indicate statistical signiﬁcance as determined by one-way
ANOVA: single asterisks, p , 0.05; double-asterisks, p , 0.01. Error bars
indicate S.E.
1224 Gordon et al.
Biophysical Journal 90(4) 1223–1231
Origin 6.1 (MicroCal, Northampton, MA) software, with a signiﬁcance level
p , 0.05 taken as indicative of signiﬁcant difference between groups.
RESULTS AND DISCUSSION
Kv2.1 activation is faster at higher
current densities
A broad range of Kv2.1 cRNA concentrations were
injected—between 1 and 30 ng per oocyte—yielding a range
of current densities between 0 and 20 mA at 0 mV membrane
potential (Fig. 1, B–D). There was a striking correlation
between current density and activation kinetics, namely that
Kv2.1 activation became faster with higher current densities
(Fig. 1, C and D). The correlation between Kv2.1 activation
rate and current density was assessed by ﬁtting activation at
0 mV with a double-exponential function, and plotting the
slow component of activation versus corresponding current
density for each oocyte (n ¼ 223 oocytes).
We hypothesized that there exists in oocytes a ﬁnite level
of an endogenous moiety that signiﬁcantly slows Kv2.1
activation at low Kv2.1-expression levels, but the effects of
which are diluted as Kv2.1 expression is increased by
injecting more Kv2.1 cRNA. This situation has parallels to
considerations of fractional occupancy of a ﬁnite number of
receptors by increasing amounts of a ligand. Thus, the scatter
plot was ﬁt with a sigmoidal curve (Fig. 1 D, solid line) (for
values, see Table 1), as would be plotted for effect versus log
of ligand concentration for studies of receptor occupancy.
Results are also shown using binning of oocytes according
to current density (Fig. 1 D, inset), showing signiﬁcant
differences between the mean activation rates of the different
groups.
Overexpressed xMiRP2 eliminates density-
dependent changes in Kv2.1 activation kinetics
Kv2.1 coassembles with MiRP2 in mammalian brain to form
a slower activating and deactivating channel than Kv2.1
alone (18). Thus, we hypothesized that xMiRP2, which is
endogenously expressed in Xenopus oocytes, might underlie
some of the density-dependent changes in Kv2.1 activation
kinetics in oocytes. First, in oocytes injected with 18 ng
Kv2.1 cRNA to give high current density, and 3 ng xMiRP2
cRNA, heterologously overexpressed xMiRP2 was found to
reduce Kv2.1 current density approximately twofold, and
slow the fast and slow components of Kv2.1 activation two-
to-fourfold, similar to results previously observed for human
MiRP2 with Kv2.1 in Chinese hamster ovary (CHO) cells
(18) (Fig. 2, A–C). When a large number of oocytes with a
range of Kv2.1 cRNA injection levels were studied, it was
noticeable that xMiRP2-Kv2.1 currents displayed a rela-
tively wide range of activation kinetics, which may be due
to differing efﬁciencies in coassembly between oocytes, or
perhaps that xMiRP2 introduces additional regulatory sites
into the channel complex (Fig. 2D). Nevertheless, the scatter
plot for xMiRP2-Kv2.1 currents could not be ﬁt with a
sigmoidal curve and instead displayed a shallow linear
relationship (Fig. 2 D, solid line, n¼ 166 oocytes; see values
in Table 1). This best-ﬁt straight line corresponded very well
to the initial part of the sigmoidal curve generated from
expression of Kv2.1 alone (Fig. 2 D, dashed line), correspond-
ing to low levels of Kv2.1 expression. Evaluation of the data
using binning according to current density (Fig. 2 D, inset)
showed that differences in activation rate between groups
were much less signiﬁcant than observed in the absence of
overexpressed xMiRP2 (Fig. 1 D, inset).
Endogenous xMiRP2 contributes to current
density-dependent changes in Kv2.1
activation kinetics
RNA interference (RNAi) was next employed to knock
down endogenous xMiRP2 expression to directly assess its
contribution to density-dependent changes in Kv2.1 activa-
tion kinetics, as previously employed to assess interaction
with hERG (31). RNA was isolated from noninjected oocytes
or oocytes injected with siRNA for xMiRP2, scrambled
siRNA, or cRNA for xMiRP2. RT-PCR to produce cDNA
was followed by normalization of samples to Xenopus
b-actin cDNA concentration (Fig. 3 A, upper panel). Next,
TABLE 1 Effects of Xenopus MinK and MiRP2 on expression level dependence of Kv2.1 activation kinetics
Sigmoidal (logistic) ﬁt A1 A2 x0 slope n R
2
Kv2.1 cRNA 181.9 6 16.3 28.0 6 5.1 0.77 6 0.10 2.93 6 0.80 223 0.53
1control siRNA 187.3 6 9.4 56.8 6 8.0 2.46 6 0.28 3.41 6 1.19 191 0.36
1xMinK siRNA 122.38 6 7.24 38.8 6 13.9 2.19 6 0.44 4.23 6 2.68 146 0.27
Linear ﬁt A B R SD n p
1xMiRP2 cRNA 148.6 6 10.6 36.4 6 8.2 0.171 117.0 166 0.048
1xMinK cRNA 266.6 6 14.7 70.5 6 2.6 0.39 105.5 56 0.0029
1xMiRP2 siRNA 71.6 6 4.2 37.8 6 7.9 0.45 38.9 95 ,0.0001
1xMiRP2/xMinK siRNA 47.1 6 1.8 15.2 6 3.3 0.50 14.7 68 ,0.0001
Scatter plots were ﬁt with a logistic dose response function, y ¼ [A1–A2/1 1 (x0/x)p] 1 A2, where x0 is the current at half-maximal effect (mA) and p is the
slope factor; R2 is the coefﬁcient of determination. Scatter plots that did not ﬁt with a logistic dose response were ﬁt with a straight line, y ¼ Bx 1 A; values
are also shown for correlation coefﬁcient (R), standard deviation (SD), and signiﬁcance level (p). In all cases, n ¼ number of oocytes per group.
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normalized cDNA samples were probed for xMiRP2 cDNA
by PCR using sequence-speciﬁc primers (Fig. 3 A, lower
panel). RNAi of endogenous xMiRP2 using xMiRP2-speciﬁc
siRNA oligos knocked down endogenous xMiRP2 mRNA
expression such that a band could no longer be detected
whereas injection of xMiRP2 cRNA increased band intensity
and control (scrambled) siRNA oligos had no effect on band
intensity (Fig. 3 A, lower panel).
Western blotting using anti-MiRP2 antibodies was used to
evaluate the efﬁciency of xMiRP2 knockdown at the protein
level (Fig. 3 B). Oocytes injected with xMiRP2 cRNA showed
a 1.8-fold increase in xMiRP2 protein, whereas oocytes
injected with xMiRP2 siRNA showed a 6.8-fold decrease in
endogenous xMiRP2 protein, as assessed by densitometry
(n ¼ 10 oocytes; similar results were obtained here in a
repeat batch, and in a previous study (31)) (Fig. 3 B).
Coinjection of Kv2.1 cRNA with scrambled control siRNA
oligos produced a current density-activation rate (slow com-
ponent of double-exponential ﬁt assessed) correlation similar
to that observed with Kv2.1 cRNA alone, indicating a lack
of nonspeciﬁc effects from coinjection of siRNA oligos (Fig.
3 C, n ¼ 191 oocytes). This scatter plot was ﬁtted with a
sigmoidal curve (values in Table 1). Mean activation rates for
oocytes binned by current density are shown for comparison
(Fig. 3 C, inset). In contrast, coinjection of xMiRP2-speciﬁc
siRNA oligos markedly altered the current density-kinetics
relationship, resulting in much more rapid Kv2.1 activation
across the Kv2.1 cRNA concentration range, and a shallower
current density-kinetics relationship (Fig. 3 D, n ¼ 95
oocytes). This scatter plot did not ﬁt with a sigmoidal func-
tion, and instead was ﬁt with a straight line (Fig. 3 D, solid
line; dashed line shows sigmoidal ﬁt of control siRNA plot
for comparison). Linear ﬁt values are given in Table 1. Much
less scatter was observed than previously seen for Kv2.1
alone or Kv2.1 with overexpressed xMiRP2, and mean acti-
vation kinetics of binned groups of oocytes (Fig. 3 D, inset)
were faster and less variable than observed with control
siRNA or Kv2.1 alone. These data suggest that endogenous
xMiRP2 modulates injected Kv2.1 function, and partially
underlies density-dependent changes in Kv2.1 activation
kinetics.
Endogenous xMinK contributes to current
density-dependent changes in Kv2.1
activation kinetics
Because xMiRP2 siRNA did not completely eliminate density-
dependent changes in Kv2.1 activation kinetics, we analyzed
the effects of a related oocyte-expressed gene, xMinK, on
Kv2.1 currents. MinK is best known for its ability to modulate
KCNQ1 in mammalian heart, generating the IKs repolariza-
tion current (8,15,16), and interaction of Kv2.1 with MinK
has not previously been reported. Studying MinK in the
Xenopus oocyte expression system presents unique chal-
lenges, because MinK upregulates endogenous oocyte
xKCNQ1 currents to produce an IKs-like current (8,16). To
FIGURE 2 Overexpressed xMiRP2 slows
Kv2.1 activation. (A) Exemplar current traces
generated from TEVC of oocytes injected
with 18 ng Kv2.1 or coinjected with 3-ng
xMiRP2 and 18-ng Kv2.1 cRNA. Oocytes
were held at80 mV and stepped to voltages
between 80 and 160 mV, with a 40 mV
tail pulse (protocol, upper inset; zero current
level, dashed line). (B) Mean current-voltage
relationships from traces in A for Kv2.1 (solid
squares) or xMiRP2-Kv2.1 (open squares)
channels in oocytes, n ¼ 13–15 oocytes.
Error bars indicate mean 6 SE. Single
asterisk indicates signiﬁcant difference be-
tween groups at 0–60 mV, p , 0.0005. (C)
Time constants for double-exponential ﬁts of
activation to peak currents for Kv2.1 (solid
squares, tslow; solid circles, tfast) and
xMiRP2-Kv2.1 (open squares, tslow; open
circles, tfast; n ¼ 13–15 oocytes per group).
The single asterisk indicates signiﬁcant dif-
ference between groups at all voltages, p ,
0.0001. (D) Scatter plot of the relationship
between the slow component of activation
(tslow) and current density for oocytes
coinjected with 1–30 ng Kv2.1 cRNA and
3 ng xMiRP2 cRNA (n¼ 166 oocytes). Solid
line indicates linear ﬁt for these data. Dashed
line indicates the sigmoidal ﬁt for Kv2.1
cRNA alone data from Fig. 1 D for comparison. (Inset) Slow component of activation kinetics versus binned current density for oocytes as in scatter plot.
Asterisk indicates statistical signiﬁcance as determined by one-way ANOVA, p , 0.05.
1226 Gordon et al.
Biophysical Journal 90(4) 1223–1231
overcome contamination from upregulated xKCNQ1, we
included HMR1556—a speciﬁc blocker of MinK-KCNQ1
currents (33–35)—in the bath medium, after ﬁrst conﬁrming
that 5 mM HMR1556 completely inhibits xMinK-xKCNQ1
but not xMinK-Kv2.1 currents in oocytes (Fig. 4 A). xMinK
reduced Kv2.1 current density fourfold (Fig. 4 B) and slowed
both fast and slow components of Kv2.1 activation two-to-
fourfold (Fig. 4 C). Overexpression of xMinK also greatly
reduced density-dependent changes in Kv2.1 activation rate,
eliminating the sigmoidal relationship between current den-
FIGURE 3 Endogenous xMiRP2 modulates Kv2.1 activation kinetics.
(A) Semiquantitative PCR of cDNA generated by RT-PCR of mRNA
isolated from Xenopus oocytes. Lanes for both gels (left to right), uninjected
oocytes (Non); oocytes injected with 3 ng positive control xMiRP2 cRNA
(M2 cRNA), 500 pg xMiRP2 siRNA (M2 siRNA), or 500 pg scrambled
control siRNA (con siRNA). (Upper panel) Xenopus mRNA normalized to
endogenous b-actin gene. Bands were generated by PCR using primers
speciﬁc for Xenopus b-actin, and indicate equal amounts of mRNA-
generated cDNA loaded in each lane. (Lower panel) PCR from cDNA
generated from Xenopus oocyte mRNA by RT-PCR, and normalized to
Xenopus b-actin (see above). Bands were generated by PCR using primers
speciﬁc for Xenopus MiRP2 and indicate speciﬁc post-transcriptional gene
silencing of xMiRP2 by xMiRP2 siRNA. (B) Western blot with anti-MiRP2
antibody of lysates from noninjected oocytes (non) or oocytes injected with
500 pg of xMiRP2 siRNA (M2 siRNA) or 3 ng xMiRP2 cRNA (M2 cRNA).
(C) Scatter plot of the relationship between the slow component of activation
(tslow) and current density for oocytes coinjected with 1–30 ng Kv2.1 cRNA
and 500 pg scrambled control siRNA (n ¼ 191 oocytes). (Inset) Slow
component of activation kinetics versus binned current density for oocytes
as in scatter plot. Asterisks indicate statistical signiﬁcance as determined by
one-way ANOVA: single asterisk, p , 0.05; double-asterisk, p , 0.01. (D)
Scatter plot of the relationship between the slow component of activation
(tslow) and current density for oocytes coinjected with 1–30 ng Kv2.1 cRNA
and 500 pg xMiRP2 siRNA (n ¼ 95 oocytes), ﬁt with a linear relationship
(solid line). Dashed line, sigmoidal ﬁt of data in C (control siRNA). (Inset)
Slow component of activation kinetics versus binned current density for
oocytes as in scatter plot. Asterisks indicate statistical signiﬁcance as deter-
mined by one-way ANOVA, p , 0.01.
FIGURE 4 Overexpressed xMinK slows Kv2.1 activation. (A) Exemplar
current traces generated from TEVC of oocytes injected with 3 ng xMinK
alone (left) or coinjected with 18 ng Kv2.1 cRNA (right), in the absence
(upper panel) or presence (lower panel) of HMR1556 (5 mM) in the bath
solution. Oocytes were held at 80 mV, then stepped to voltages between
80 mV and160 mV with a40 mV tail pulse (for protocol, see inset). (B)
Mean current-voltage relationships from traces as in A for Kv2.1 (solid
squares) or xMinK-Kv2.1 (open squares) channels, n ¼ 15 oocytes per
group. Error bars indicate mean 6 SE. Single asterisk indicates signiﬁcant
difference between groups at 0–60 mV, p , 0.001. (C) Time constants for
double-exponential ﬁts of activation to peak currents for Kv2.1 (solid
square, tslow; solid circle, tfast; and xMinK-Kv2.1: open square, tslow; open
circle, tfast; and n ¼ 15 oocytes per group). Error bars indicate SEM. The
single asterisk indicates signiﬁcant difference between groups at 20–60 mV,
p , 0.05. The double-asterisk indicates signiﬁcant difference between
groups at 0–60 mV, p, 0.0001. (D) Scatter plot of the relationship between
the slow component of activation (tslow) and current density for oocytes
coinjected with 1–30 ng Kv2.1 cRNA and 3 ng xMinK cRNA (n ¼ 56
oocytes); solid line is a linear ﬁt of the data. Dashed line, sigmoidal ﬁt of data
from Fig. 1 D (Kv2.1 cRNA alone). (Inset) Slow component of activation
kinetics versus binned current density for oocytes as in scatter plot.
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sity and activation rate and instead showing a relatively shal-
low linear correlation (Fig. 4 D, solid line, n ¼ 56 oocytes;
dashed line shows ﬁt for Kv2.1-alone scatter plot, for
comparison) (values in Table 1). Binning of data by current
density (Fig. 4 D, inset) revealed universally slow mean
activation kinetics, with no signiﬁcant differences between
groups, showing that xMinK overexpression eliminates
density-dependent changes in Kv2.1 activation kinetics.
Next, effects of endogenous xMinK on Kv2.1 activation
kinetics were assessed using RNAi knockdown of xMinK.
To assess efﬁciency of xMinK RNAi, RNA was isolated
from noninjected oocytes or oocytes injected with siRNA for
xMinK, scrambled siRNA, or cRNA for xMinK. RT-PCR to
produce cDNA was followed by normalization of samples to
Xenopus b-actin cDNA concentration (Fig. 5 A, upper
panel). Normalized cDNA samples were probed for xMinK
cDNA by PCR using sequence-speciﬁc primers (Fig. 5 A,
lower panel). Injection with scrambled control siRNA oligos
did not alter band intensity of ampliﬁed xMinK cDNA
compared to noninjected oocytes, whereas an xMinK band
was not observed in cDNA samples obtained from batches
of oocytes injected with xMinK siRNA. Injection of 3 ng
xMinK cRNA, in contrast, increased band intensity of ampli-
ﬁed xMinK cDNA (n ¼ 10 oocytes).
Coinjection of xMinK siRNA oligos with Kv2.1 cRNA
gave rise to currents with reduced current density-dependence
of activation kinetics compared to Kv2.1 alone, assessed by
plotting the slow component of Kv2.1 activation versus
current density (Fig. 5 B). The scatter plot was ﬁtted with a
sigmoidal function (solid line, n ¼ 146 oocytes, values in
Table 1), showing overall faster activation at a given current
density compared to that observed with control siRNA
(dashed line). This effect was also apparent from a plot of
mean activation kinetics for groups of oocytes binned by
current density (Fig. 5 B, inset). This suggests that endog-
enous xMinK, like xMiRP2, contributes to density-dependent
changes in Kv2.1 activation kinetics.
Endogenous xMiRP2 and xMinK are necessary
and sufﬁcient for current density-dependent
changes in Kv2.1 activation kinetics
These data raised the possibility that coinjection of speciﬁc
siRNA oligos for both xMinK and xMiRP2 might further
reduce the correlation between Kv2.1 current density and
activation kinetics. Coinjection of both xMinK and xMiRP2
siRNA oligos with a range of Kv2.1 cRNA concentrations
produced an almost complete loss of the current density-
kinetics relationship for Kv2.1, assessed by a scatter plot of
the slow component of Kv2.1 activation versus current
density (Fig. 5 C, n¼ 68 oocytes). This scatter plot could not
be ﬁt with a sigmoidal relationship, and therefore was instead
ﬁtted with a linear relationship (Fig. 5 C, solid line). This line
had a slope one-half that of the slope for xMiRP2 siRNA
alone (long-dashed line is the linear ﬁt of xMiRP2-siRNA-
FIGURE 5 Endogenous xMinK and xMiRP2 are necessary and sufﬁcient
to explain the correlation between Kv2.1 expression level and activation
kinetics. (A) Semiquantitative PCR of cDNA generated by RT-PCR of
mRNA isolated from Xenopus oocytes. Lanes for both gels (left to right)
uninjected oocytes (Non); oocytes injected with 3 ng positive control xMinK
cRNA (MinK cRNA), 500 pg xMinK siRNA (MinK siRNA), or 500 pg
scrambled control siRNA (con siRNA). (Upper panel) Xenopus mRNA
normalized to endogenous b-actin gene. Bands were generated by PCR
using primers speciﬁc for Xenopus b-actin, and indicate equal amounts of
mRNA-generated cDNA loaded in each lane. (Lower panel) PCR from
cDNA generated from Xenopus oocyte mRNA by RT-PCR, and normalized
to Xenopus b-actin (see above). Bands were generated by PCR using
primers speciﬁc for XenopusMinK and indicate speciﬁc post-transcriptional
gene silencing of xMinK by xMinK siRNA. (B) Scatter plot of the
relationship between the slow component of activation (tslow) and current
density for oocytes coinjected with 1–30 ng Kv2.1 cRNA and 500 pg
xMinK siRNA (n ¼ 146 oocytes). Solid line indicates sigmoidal ﬁt of data.
Dashed line, sigmoidal ﬁt of data in Fig. 3 C (control siRNA). (Inset) Slow
component of activation kinetics versus binned current density for oocytes
as in scatter plot. Asterisks indicate statistical signiﬁcance as determined by
one-way ANOVA: single, p, 0.05; double, p, 0.01. (C) Scatter plot of the
relationship between the slow component of activation (tslow) and current
density for oocytes coinjected with 1–30 ng Kv2.1 cRNA, 500 pg xMinK
siRNA and 500 pg xMiRP2 siRNA (n ¼ 68 oocytes). Solid line indicates
linear ﬁt of data. Short-dashed line, sigmoidal ﬁt of data in Fig. 3 C (control
siRNA); long-dashed line, linear ﬁt of data in Fig. 3 D (xMiRP2 siRNA).
(Inset) Slow component of activation kinetics versus binned current density
for oocytes as in scatter plot. Asterisk indicates statistical signiﬁcance as
determined by one-way ANOVA, p , 0.05.
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alone data, shown for comparison, from Fig. 3 D). The
sigmoidal relationship for control siRNA is also shown
(short-dashed line) for comparison (all values in Table 1).
Comparison of activation kinetics for oocytes binned by cur-
rent density showed relatively fast activation for all groups,
with relatively little variation between groups (Fig. 5 C,
inset). These data strongly suggest that endogenous oocyte
xMiRP2 and xMinK both regulate the gating kinetics of
overexpressed Kv2.1 in oocyte expression experiments, and
are the dominant mechanism behind density-dependent
changes in Kv2.1 activation kinetics in oocytes.
Endogenous xMiRP2 and xMinK reduce Kv2.1
current density
Analysis of the effects of overexpressed xMiRP2 or xMinK
on Kv2.1 showed that either subunit reduces Kv2.1 current
density, in addition to effects on gating (Fig. 2, A and B, and
Fig. 4 B). These data suggest that Kv2.1 current density
should increase nonlinearly with increased cRNA concen-
tration, and also that injection of xMiRP2 or xMinK siRNA
should increase Kv2.1 current density at lower Kv2.1 cRNA
concentrations. We examined a subset of time-matched re-
cordings of Kv2.1 at various cRNA concentrations per-
formed on the same day with the same batch of oocytes, and
found that current density increased in a nonlinear fashion,
which could be ﬁtted with a single-exponential function
(Fig. 6 A). This likely reﬂects the beginning of a relationship
which would adopt a sigmoidal function if injection of much
higher amounts of Kv2.1 cRNA were possible, but this was
avoided because of potential artifacts due to overwhelming
of oocyte translation processes. The nonlinear relationship is
consistent with a greater proportional inﬂuence of endoge-
nous xMiRPs at lower Kv2.1 cRNA concentrations, with
according lower current density at these expression levels
due to the partially suppressive effects of endogenous xMinK
and xMiRP2.
Similarly, a comparison of Kv2.1 current density at a
single cRNA concentration (5 ng) with or without xMiRP2
or xMinK siRNA for time-matched recordings performed
on another batch of oocytes showed signiﬁcantly increased
current density with the coinjection of xMiRP2 or xMinK
siRNA. This increase in current density was not observed
with coinjection of control siRNA (Fig. 6 B). These data are
again consistent with the partially suppressive effects of
either endogenous subunit, and relief of these effects by
siRNA knockdown.
CONCLUSIONS
The dependence of biophysical properties on expression
level has been previously observed for several potassium
channel types heterologously expressed in Xenopus oocytes.
A study of Kv1.2 channels showed that injection of 0.2 ng
Kv1.2 cRNA yields very slowly-inactivating current sensi-
tive to dendrotoxin I (IC50 ¼ 2 nM), whereas injection of 20
ng Kv1.2 cRNA generates a noninactivating current which is
much less sensitive to dendrotoxin (IC50 ¼ 200 nM) (27).
Similarly, injection of low levels of Kv1.3 cRNA into
Xenopus oocytes produced a transient potassium current
which was completely inhibited by 10 nM charybdotoxin,
whereas high levels of cRNA produced noninactivating
current which was hardly sensitive to 10 nM charybdotoxin
(28). Further, although low levels of Shaker channel ShH4
expression in Xenopus oocytes produce a transient, tetrae-
thylammonium-sensitive current, higher expression levels give
rise to a slower inactivating current with reduced tetraethy-
lammonium sensitivity (29). Expression level-dependent dif-
ferences in the properties of Kv channels are also observed
with coexpression of two different channel types: coex-
pression of Eag and Sh channel subunits in Xenopus oocytes
leads to accelerated decay of the Sh current, but only at
higher expression levels (26). These types of effects are not
limited to mammalian potassium channels: the inwardly-
rectifying KAT1 channel from Arabidopsis thaliana showed
different gating and sensitivity to external cesium ions
depending upon the amount of cRNA injected (30). Some of
FIGURE 6 Endogenous xMinK and xMiRP2 reduce current density of
heterologously expressed Kv2.1. (A) Plot of the relationship between the
amount of Kv2.1 cRNA injected and current density at 0 mV, for oocytes
coinjected with 1–30 ng Kv2.1; n¼ 23–75 oocytes per data point. Solid line
indicates single exponential ﬁt of data: R2 ¼ 0.97, A ¼ 0.58 6 0.03, and
t ¼ 11.57863 6 0.40. Error bars indicate mean 6 SE. (B) Bar graph of
the effects of siRNA-coinjection on Kv2.1 current density (24–36 h post-
injection) at 0 mV with 5 ng Kv2.1 cRNA injected; n ¼ 18–23 oocytes per
data set. (Solid bar, Kv2.1 alone; shaded bar, Kv2.1 1 500 pg control
siRNA; open bar, labeled ‘‘1 xM2 siRNA’’, Kv2.1 1 500 pg xMiRP2
siRNA; and open bar, labeled ‘‘1 xMinK siRNA’’, Kv2.11 500 pg xMinK
siRNA.) Asterisks indicate statistical signiﬁcance as determined by one-way
ANOVA: single asterisk, p , 0.05; double-asterisk, p , 0.005. NS ¼ not
signiﬁcant; p . 0.05. Error bars indicate mean 6 SE.
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the previously described effects have been ascribed to
increased clustering of channels at higher expression levels,
and may involve interaction with cytoskeletal elements, i.e.,
with Kv1.3 (28), but this has not been shown in the major-
ity of cases. Here, we demonstrate that expression level-
dependent changes in Kv2.1 activation kinetics can be
entirely explained by interaction with endogenous xMiRP2
and xMinK.
Previously, the discovery of a family of MiRPs in Xenopus
oocytes led to the ﬁnding that at low levels of hERG
expression, endogenous xMiRP2 can suppress hERG cur-
rents almost entirely, whereas at higher hERG levels these
effects are diluted until at 5 mA, hERG tail currents effects
are minimal (31). These followed from previous ﬁndings that
overexpressed mammalian MiRP2 suppresses hERG cur-
rents in oocytes (17). The current ﬁnding that endogenous
xMiRP2 and xMinK signiﬁcantly slow the activation
kinetics of heterologously expressed Kv2.1 even at relatively
high overexpression levels (.1 mA current density at 0 mV)
provides the ﬁrst example of an endogenous potassium chan-
nel ancillary subunit, altering potassium channel gating
attributes according to a-subunit expression level. We
recently found that human MiRP2 slows Kv2.1 activation
in CHO cell coexpression studies, and that MiRP2 forms
complexes with Kv2.1 in rat brain membranes (18), but
interaction of MinK and Kv2.1 has not previously been
reported. Using BLAST homology searches, we have not yet
found a Xenopus variant of MiRP1. Interestingly, in this
study we found that neither human MinK nor human
MiRP2 have any effects on rat or human Kv2.1 properties in
Xenopus oocyte coexpression experiments (data not shown),
again demonstrating that MiRP-a subunit interaction can
show species- and expression-system dependence. However,
ongoing studies in our lab show that human variants of MinK
and MiRP1, and the rat variant of MinK, modulate Kv2.1 in
CHO cell coexpression studies in a similar fashion to effects
seen here with Xenopus MiRPs and rat Kv2.1 in oocytes
(unpublished data). We also previously found that rat MiRP1
but not human MiRP1 modulates Kv3.1 and Kv3.2
a-subunits in CHO cell coexpression studies (19). As yet,
the mechanisms for this species- and expression-system
dependence have not been elucidated, but they provide
another stumbling block in our efforts to understand MiRP
physiology.
In summary, the data presented here provide a molecular
mechanism for expression-level dependence of Kv2.1 chan-
nel properties that may also explain previously-observed
density-dependent variation in the biophysical properties of
other channels. Although effects of endogenous factors such
as MiRPs can be overcome with high expression levels of
a-subunits, this is not always feasible, particularly when
single-channel analyses are desired; thus in some cases,
coinjection of xMiRP-speciﬁc siRNA oligos may provide a
solution to these potential problems. Further studies will be
required to assess whether xMiRPs contribute to pharmaco-
logical properties of channels such as Kv2.1 in Xenopus
oocytes, signiﬁcant because the oocyte expression system is
widely used both in initial electrophysiological studies of
ion-channel pharmacology and also in industry for medium
throughput screening of pharmacological agents.
XenopusMiRPs may also explain inconsistencies between
studies from different laboratories of the same channel
subunits—we previously found that at low levels of hERG
expression, endogenous xMiRP2 could reverse the effects of
coexpressed human MiRP1 on hERG channels, with MiRP1
increasing hERG currents at low levels presumably by rescue
from interaction with endogenous xMiRP2 (31). The pres-
ence or absence of particular MiRPs, and the relative ex-
pression of various a-subunits compared to available MiRPs
within a particular cell in vivo, may provide a physiological
mechanism for producing and dynamically regulating the
properties of Kv currents, thus explaining variable properties
of a particular channel type depending upon the cell type,
developmental stage, or disease state studied (36,37).
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